Multiple Myeloma Awareness Month, sponsored by the Leukemia and Lymphoma Society educates the public that myeloma is a type of blood cancer that begins in the bone marrow. It forms in the body’s plasma cells, which are a type of white blood cell that normally helps to fight infections. When myeloma cells multiply beyond control and overtake the normal plasma cells, they cause serious medical complications.
Symptoms of those with Multiple Myeloma differ. People with Myltiple Myeloma may feel fatigued and short of breath on exertion. Less common, when the white blood cell count is low, patients will have an increased risk of infection. People with bone lesions may have pain.
For a very small percentage of patients, myeloma is hereditary. Others have been exposed to environmental toxins such as high doses of radiation or to Agent Orange during the Vietnam War. Most people, however, don't have a family history or known environmental exposure.
Multiple Myeloma Awareness Month tells us that more than 30,000 people will be diagnosed and almost 13,000 people will die from myeloma. Today, almost 120,000 people are living with, or in remission, from myeloma.
While the disease remains incurable, treatment advancements over the past decade are resulting in better overall survival, and new therapeutic approaches are being studied. Still, there is much work to be done.
To address this urgent, unmet medical need, the Leukemia and Lymphoma Society is taking a multi-pronged approach to improve outcomes for patients, by investing in scientific research as well as education and outreach efforts to improve patient access to the most promising, cutting-edge treatments.
The awareness color for Multiple Myeloma is Burgundy.
Personalized Cause supports Multiple Myeloma Awareness Month with: